Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas

• Ngā kaituhi matua: Laura Eibenschutz (Author), Delia Colombo (Author), Caterina Catricalà (Author)
• Hōputu: Pukapuka
• I whakaputaina: Hindawi Limited, 2013-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been shown to have antineoplastic activity in addition to its use as an immunosuppressive agent for the prevention of organ transplant rejection. We report the use of everolimus for the compassionate treatment of four eld...